Evidence supporting the use of: Vitamin E (alpha tocopheryl)
For the health condition: Cataracts

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Vitamin E (alpha-tocopherol) has been investigated for its potential role in the prevention and management of cataracts due to its antioxidant properties. The rationale is that oxidative stress contributes to cataract formation by damaging lens proteins and lipids, and antioxidants like Vitamin E may help counteract this process. Epidemiological studies have generally shown an association between higher dietary intake or blood levels of Vitamin E and a reduced risk of cataracts. For example, some cohort studies report a modest inverse relationship between Vitamin E intake and cataract incidence. Additionally, laboratory studies demonstrate that Vitamin E can protect lens tissues from oxidative damage in vitro.

However, randomized controlled trials (RCTs) examining Vitamin E supplementation have produced inconsistent results. Large trials such as the Age-Related Eye Disease Study (AREDS) and others have not found a significant benefit of Vitamin E supplementation alone in preventing cataract development or progression. Meta-analyses of RCTs generally conclude that Vitamin E supplementation does not significantly reduce cataract risk, though some studies suggest a possible benefit in specific subgroups or in combination with other antioxidants.

In summary, there is a scientific basis for considering Vitamin E in cataract prevention due to its antioxidant effects, and observational studies provide some supportive evidence. However, high-quality clinical trials overall do not support a strong effect. Thus, the evidence for its use is limited (rated 2 out of 5).

More about Vitamin E (alpha tocopheryl)
More about Cataracts

Products containing Vitamin E (alpha tocopheryl)

We currently have no products on Vitabase that contain this ingredient.